Clinical Trial Update: Study Evaluating Oral MOA-728 For The Treatment Of OIBD In Subjects With Chronic Non-Malignant Pain [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating oral MOA-728 for treating opioid-induced bowel dysfunction in adults with chronic non-malignant pain; results posted after com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Constipation
• Opioid-induced Constipation

Drugs mentioned

• MOA-728

Snippet

Sponsor: Bausch Health Americas, Inc. | Conditions: Constipation | Phase 2 | Status: COMPLETED | Results posted: 2020-08-20